301 results
8-K
EX-99.1
NAVB
Navidea Biopharmaceuticals, Inc.
2 Jun 23
Entry into a Material Definitive Agreement
6:14pm
and an expert in the industry, with a career progression that includes research, commercial development, product strategy and proven leadership at all
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
13 Apr 23
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
5:24pm
research and development, current and planned manufacturing or distribution methods and processes, customer lists, current and anticipated customer … Products, including, as applicable, research and development activities, clinical trials and Regulatory Approvals, to the extent relating to a Milestone
8-K
EX-99.1
iqti 1ybl4
15 Nov 22
Navidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results
4:00pm
8-K
EX-99.1
32oml y1cs
12 May 22
Navidea Biopharmaceuticals Reports First Quarter 2022 Financial Results
4:02pm
8-K
EX-4.1
4sz0j75 zmu1
12 Apr 22
Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American
4:11pm
8-K
EX-99.1
rdnz5mu3 p61
23 Mar 22
Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial Results
4:31pm
8-K
EX-99.1
z08 ggkpx
10 Nov 21
Navidea Biopharmaceuticals Reports Third Quarter 2021 Financial Results
4:26pm
8-K
EX-99.1
ddld1qey8
11 Aug 21
Navidea Biopharmaceuticals Reports Second Quarter 2021 Financial Results
4:22pm